With FDA nod, ChemoCentryx pill stands out in a sea of injectable & infused meds

Healthcare

ChemoCentryx has spent decades developing oral alternatives to injectable and infused biologic drugs that treat chronic autoimmune conditions. The research finally paid off with FDA approval of Tavneos, a ChemoCentryx pill for a rare autoimmune disease.

Leave a Reply